[Interim efficacy of a multicenter cohort study for China Net Childhood Lymphoma mature B-cell lymphoma 2017 regimen in the treatment of pediatric High-grade-B cell lymphoma].

Yang Zhao; Shaojun Huang; Yibin Jia; L P Zhang; Yanlong Duan; Ling Jin; X W Zhai; H S Wang; Bo Hu; Ying Liu; Anqi Liu; Wei Liu; M C Zheng; Fanrong Li; Longhua Sun; Xiaojun Yuan; Y P Dai; B X Zhang; Liang Jiang; X G Wang; Huimin Wang; Chunju Zhou; Ziqing Gao; Y H Zhang

doi:10.3760/cma.j.cn112137-20240305-00490

Abstract

To analyze the mid-term efficacy of the China Net Childhood Lymphoma mature B-cell lymphoma 2017 (CNCL-B-NHL-2017) regimen in treating children with high-grade B-cell lymphoma (HGBL).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhao et al. (2024) studied this question.

synapsesocial.com/papers/68e5e8eeb6db64358757d83e https://doi.org/10.3760/cma.j.cn112137-20240305-00490

View Full Paper

Ask AI

Bookmark

Share

[Interim efficacy of a multicenter cohort study for China Net Childhood Lymphoma mature B-cell lymphoma 2017 regimen in the treatment of pediatric High-grade-B cell lymphoma].

Abstract

Discussion

Cite This Study

[Interim efficacy of a multicenter cohort study for China Net Childhood Lymphoma mature B-cell lymphoma 2017 regimen in the treatment of pediatric High-grade-B cell lymphoma].

Abstract

Discussion

Cite This Study

Keep reading

Keep reading